Precision Medicine Online provides the latest news for healthcare leaders and scientists interested in precision medicine and individualized approaches to treatment and prevention.

2025年1月20日 · The Shanghai-based firm will test the gene therapy candidate in patients between 4 and 9 years old with Duchenne muscular dystrophy.

2025年1月20日 · The latest news on companion diagnostics and personalized cancer therapy from Precision Medicine Online.

2024年12月30日 · NEW YORK – In 2024, Precision Medicine Online readers were most interested in stories tracking the implementation of personalized treatments and tests for cancer, cardiovascular disease, and rare conditions. An annual survey tracking the investments US cancer centers and hospitals are making in precision …

Precision Medicine Online is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics.

2024年12月5日 · The firm said it struck a three-year licensing deal with a top pharmaceutical company that will use the data to advance GLP-1 receptor agonist research. CellCarta, Biofidelity Partner to Offer Lung Cancer Assay for Clinical Trials CellCarta will validate Biofidelity's Aspyre Lung assay in its ...

2025年1月9日 · News on lab-developed tests, emerging diagnostic technologies and tests from Precision Medicine Online.

2024年11月18日 · The latest research news in genetics and genomics from Precision Medicine Online.

2024年11月15日 · The EC considered the treatment's activity in patients with advanced, PD-L1-positive esophageal and gastric cancers in the RATIONALE-305 and -306 trials.

2025年1月22日 · The companies will focus on advancing AXV-101, with which they hope to treat retinal dystrophy by targeting mutations in the BBS1 gene. Doctors and patient advocates supporting pretreatment testing at times challenged FDA and other experts who aren't swayed by available evidence. Galapagos Inks Deal ...